Cresco Labs Strengthens Balance Sheet with $325M Refinancing Deal, Cuts Total Debt

Cresco Labs Extends Debt With $325 Million at 12.5% Due in 2030 - Cannabis News World

Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing Transaction Extends Maturity to 2030, Strengthens Balance Sheet and Positions Company for Growth CHICAGO–(BUSINESS WIRE)– Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the closing of its previously announced refinancing of the Company’s senior secured credit facility.

Cresco Labs Extends Debt With $325 Million at 12.5% Due in 2030

Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing Transaction Extends Maturity to 2030, Strengthens Balance Sheet and Positions Company for Growth CHICAGO–(BUSINESS WIRE)– Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs" or the "Company"), today announced the closing of its previously announced refinancing of the Company's senior secured credit facility. [ . . . ]

Cresco Labs Strengthens Balance Sheet with $325M Refinancing Deal, Cuts Total Debt

Cannabis operator reduces debt burden and gains flexibility with new 12.5% interest loan, including option to prepay $125M at lower premium. Enhanced terms support growth strategy.